PHAT (STOCKS)
Phathom Pharmaceuticals, Inc. Common Stock
$11.840000
-0.390000 (-3.19%)
Prev close: $12.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Steven L. Basta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $941.10M
- Employees
- 427
- P/E (TTM)
- -3.15
- P/B (TTM)
- -2.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $147.19M |
| Benefits Costs and Expenses | $421.74M |
| Cost Of Revenue | $18.77M |
| Costs And Expenses | $421.74M |
| Gross Profit | $128.42M |
| Nonoperating Income/Loss | -$61.08M |
| Operating Expenses | $341.90M |
| Selling, General, and Administrative Expenses | $308.03M |
| Research and Development | $33.87M |
| Operating Income/Loss | -$213.47M |
| Income/Loss From Continuing Operations After Tax | -$274.55M |
| Income/Loss From Continuing Operations Before Tax | -$195.07M |
| Net Income/Loss | -$274.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$274.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$274.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.76 |
| Diluted Earnings Per Share | -$3.76 |
| Basic Average Shares | 75,248,575 |
| Diluted Average Shares | 75,248,575 |
| Assets | $240.29M |
| Current Assets | $207.78M |
| Accounts Receivable | $55.79M |
| Inventory | $3.61M |
| Other Current Assets | $148.38M |
| Noncurrent Assets | $32.51M |
| Fixed Assets | $1.16M |
| Other Non-current Assets | $31.35M |
| Liabilities | $662.82M |
| Current Liabilities | $93.12M |
| Accounts Payable | $1.08M |
| Other Current Liabilities | $92.05M |
| Noncurrent Liabilities | $569.70M |
| Long-term Debt | $207.09M |
| Other Non-current Liabilities | $362.61M |
| Equity | -$422.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$422.53M |
| Liabilities And Equity | $240.29M |
| Net Cash Flow From Operating Activities | -$225.23M |
| Net Cash Flow From Operating Activities, Continuing | -$225.23M |
| Net Cash Flow From Investing Activities | -$147.00K |
| Net Cash Flow From Investing Activities, Continuing | -$147.00K |
| Net Cash Flow From Financing Activities | $25.86M |
| Net Cash Flow From Financing Activities, Continuing | $25.86M |
| Net Cash Flow | -$199.52M |
| Net Cash Flow, Continuing | -$199.52M |
| Comprehensive Income/Loss | -$274.55M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$274.55M |
| Other Comprehensive Income/Loss | $0.00 |